赋能初创科企成长,破局“轻资产”融资
Xin Hua Ri Bao·2025-10-13 05:09

Core Insights - Start-up technology companies face significant financing challenges due to long project construction cycles and insufficient initial collateral, which restricts their development [1] - Tai Xing Rural Commercial Bank has introduced an innovative financial service mechanism focusing on "prospective assessment + sufficient rapid loan disbursement" to support the growth of these companies [1] Group 1: Financial Service Mechanism - The bank has shifted from traditional collateral-based credit assessment to a "value-oriented" evaluation system that emphasizes future value and growth potential of enterprises [1] - A multi-dimensional "prospective assessment" model has been established, focusing on technological strength, team capability, and market profitability [1] - The bank simplifies the loan process by allowing "land use rights collateral + guarantees," significantly reducing financing cycles [1] Group 2: Case Study of a Pharmaceutical Company - Tai Xing Pharmaceutical Company is a major local project developing innovative drugs with independent intellectual property rights targeting various medical conditions [2] - The company boasts a strong team, including members with prestigious backgrounds and significant research capabilities, and has established joint laboratories with universities [2] - The company has advanced technology that shortens the drug discovery and delivery cycle to 3-6 months, addressing key challenges in global drug discovery [2] Group 3: Project Financing and Support - During the first phase of the project, the bank proactively provided sufficient rapid loans, ensuring seamless integration of financing with project construction [3] - The bank conducted pre-approval assessments based on the company's technological strength, team background, market prospects, and profitability, enhancing decision-making speed [3] - A total of 150 million yuan was disbursed to match the project's construction progress, with a commitment to provide ongoing diversified financing support throughout the company's lifecycle [3]